Clinical Trial Update: Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the combination of pazopanib and pemetrexed in advanced non-small cell lung cancer; results were posted in February 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pazopanib (Pazopanib)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 2 | Status: COMPLETED | Results posted: 2012-02-16